BEVERIDGE, ROY A 4
4 · Epizyme, Inc. · Filed May 19, 2022
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
BEVERIDGE, ROY A
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-17+41,006→ 41,006 totalExercise: $0.56Exp: 2032-05-16→ Common Stock (41,006 underlying) - Award
Common Stock, par value $0.0001
2022-05-17+8,994→ 37,109 total
Footnotes (2)
- [F1]Consists of shares of Common Stock issuable under 8,994 restricted stock units ("RSUs") granted on May 17, 2022, which RSUs are scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service as a director. Each RSU represents the right to receive one share of Common Stock upon vesting. In the event of a change in control of the Issuer, the RSUs will vest in full.
- [F2]This option was granted on May 17, 2022 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full.